2022 annual financial data
Recursion Pharmaceuticals 2022 Operating margin
Recursion Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -619.26%.
Operating income was -245,727,000 USD and net income was -239,421,000 USD.
Operating cash flow was -83,524,000 USD.
Get free Recursion Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 39,681,000 USD
- Operating income
- -245,727,000 USD
- Net income
- -239,421,000 USD
- Operating cash flow
- -83,524,000 USD